Fisher Asset Management
LXRX icon

Fisher Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Fisher Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-523,394
Closed -$1.2M – 1232
2023
Q2 		$1.2M Sell
523,394
-126,332
-19% -$335K ﹤0.01% 743
2023
Q1 		$1.58M Sell
649,726
-70,517
-10% -$162K ﹤0.01% 690
2022
Q4 		$1.38M Buy
720,243
+114,715
+19% +$244K ﹤0.01% 716
2022
Q3 		$1.45M Hold
605,528
– – ﹤0.01% 623
2022
Q2 		$1.13M Buy
605,528
+237,334
+64% +$453K ﹤0.01% 616
2022
Q1 		$770K Buy
368,194
+197,424
+116% +$547K ﹤0.01% 653
2021
Q4 		$673K Buy
+170,770
New +$829K ﹤0.01% 703

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Fisher Asset Management's LXRX Position: Q3 2023 in Review

Fisher Asset Management sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2023, closing a stake of 523,394 shares — an estimated $1.2M sold.

Fisher Asset Management first reported a position in LXRX in Q4 2021 and held it in 7 quarters. The position peaked at $1.58M in Q1 2023. 112 funds tracked by Wall St. Rank hold LXRX as of Q3 2023.

  • Fisher Asset Management reported no remaining Lexicon Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Fisher Asset Management sold 523,394 Lexicon Pharmaceuticals shares in Q3 2023, an estimated $1.2M.
  • Fisher Asset Management first reported a position in Lexicon Pharmaceuticals in Q4 2021 and held it in 7 quarters.
  • Fisher Asset Management's Lexicon Pharmaceuticals position peaked at $1.58M in Q1 2023.
  • 112 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2023.

Based on Fisher Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.